Cardiff Oncology Inc (CRDF)
4.18
-0.18
(-4.13%)
USD |
NASDAQ |
Apr 23, 16:00
4.18
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Shareholders Equity (Quarterly): 69.74M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 69.74M |
September 30, 2023 | 77.83M |
June 30, 2023 | 86.58M |
March 31, 2023 | 96.50M |
December 31, 2022 | 106.34M |
September 30, 2022 | 113.21M |
June 30, 2022 | 120.47M |
March 31, 2022 | 130.10M |
December 31, 2021 | 140.42M |
September 30, 2021 | 133.54M |
June 30, 2021 | 138.92M |
March 31, 2021 | 124.82M |
December 31, 2020 | 128.16M |
September 30, 2020 | 33.52M |
June 30, 2020 | 24.38M |
March 31, 2020 | 6.143M |
December 31, 2019 | 7.311M |
September 30, 2019 | 6.656M |
June 30, 2019 | 8.848M |
March 31, 2019 | 9.686M |
December 31, 2018 | 10.08M |
September 30, 2018 | 13.98M |
June 30, 2018 | 17.48M |
March 31, 2018 | 4.679M |
December 31, 2017 | 6.506M |
Date | Value |
---|---|
September 30, 2017 | 3.945M |
June 30, 2017 | 3.511M |
March 31, 2017 | 10.68M |
December 31, 2016 | 19.77M |
September 30, 2016 | 26.77M |
June 30, 2016 | 32.57M |
March 31, 2016 | 41.16M |
December 31, 2015 | 48.70M |
September 30, 2015 | 54.86M |
June 30, 2015 | 18.12M |
March 31, 2015 | 23.56M |
December 31, 2014 | 8.350M |
September 30, 2014 | 12.35M |
June 30, 2014 | 17.33M |
March 31, 2014 | 17.75M |
December 31, 2013 | 20.39M |
September 30, 2013 | 21.14M |
June 30, 2013 | -2.471M |
March 31, 2013 | 1.536M |
December 31, 2012 | 2.169M |
September 30, 2012 | 4.975M |
June 30, 2012 | 5.489M |
March 31, 2012 | -4.334M |
December 31, 2011 | -4.231M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.143M
Minimum
Mar 2020
140.42M
Maximum
Dec 2021
81.76M
Average
96.50M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
BioVie Inc | 7.491M |
Perspective Therapeutics Inc | 75.18M |
Biolase Inc | 1.956M |
Tenon Medical Inc | 0.778M |
Adial Pharmaceuticals Inc | 4.084M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 81.64M |
Total Liabilities (Quarterly) | 11.90M |
Current Ratio | 7.415 |